Abiopharma

REGENXBIO Announces Regulatory Update on Ultra Rare MPS Programs

TVTX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm

Insmed to Present Multiple Abstracts on Treprostinil Palmitil Inhalation Powder (TPIP) at Pulmonary Vascular Research Institute (PVRI) 2026 Congress

Teva Pharmaceutical Industries Ltd. - Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecutive Year of Growth; Pipeline Positioned to Unlock Significant Value Potential

Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecutive Year of Growth; Pipeline Positioned to Unlock Significant Value Potential

CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation

Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR

Satellos Announces Share Consolidation in Connection with Proposed Nasdaq Listing

Halozyme - Halozyme Raises 2025 Revenue Estimates, Raises 2026 and Multi-Year Financial Guidance

Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers

General Announcement: Minutes of Extraordinary General Meeting held on 29 December 2025

Danaher Reports Fourth Quarter and Full Year 2025 Results

Financial Statements And Related Announcement - Notification Of Results Release

Financial Statements and Related Announcement: Notification of Results Release

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016